Differences in Baseline Characteristics and Outcome Among Responders, Late Responders, and Never-Responders After Anterior Cruciate Ligament Reconstruction.


Journal

The American journal of sports medicine
ISSN: 1552-3365
Titre abrégé: Am J Sports Med
Pays: United States
ID NLM: 7609541

Informations de publication

Date de publication:
12 2021
Historique:
pubmed: 2 11 2021
medline: 27 1 2022
entrez: 1 11 2021
Statut: ppublish

Résumé

Loss to follow-up in registry studies might affect generalizability and interpretation of results. To evaluate the effect of nonresponder bias in our anterior cruciate ligament (ACL) registry. Case-control study; Level of evidence, 3. A total of 2042 patients with ACL reconstruction in the Hospital for Special Surgery ACL Registry between 2009 and 2013 were included in the study. Patients who completed the patient-reported outcome measures at 2 or 5 years were considered responders (n = 808). Baseline data and patient characteristics were compared between responders and nonresponders (n = 1234). Both responders and nonresponders were contacted and invited to complete the International Knee Documentation Committee (IKDC) and Marx scores electronically and respond to questions regarding return to sports and subsequent surgeries. Nonresponders who completed the questionnaires after reminders were considered late responders. The remaining nonresponders were considered never-responders. The late responders (n = 367) completed the questionnaires after a mean follow-up of 7.8 years (range, 6.7-9.6 years), while follow-up for the responders was 6.8 years (range, 5.0-9.7 years). Responders and late responders were then compared in terms of differences in IKDC and Marx scores from baseline to final follow-up. Nonresponders were younger (28.5 vs 31.5 years; There was no difference in clinical outcome as evaluated using IKDC and Marx scores between responders and late responders.

Sections du résumé

BACKGROUND
Loss to follow-up in registry studies might affect generalizability and interpretation of results.
PURPOSE
To evaluate the effect of nonresponder bias in our anterior cruciate ligament (ACL) registry.
STUDY DESIGN
Case-control study; Level of evidence, 3.
METHODS
A total of 2042 patients with ACL reconstruction in the Hospital for Special Surgery ACL Registry between 2009 and 2013 were included in the study. Patients who completed the patient-reported outcome measures at 2 or 5 years were considered responders (n = 808). Baseline data and patient characteristics were compared between responders and nonresponders (n = 1234). Both responders and nonresponders were contacted and invited to complete the International Knee Documentation Committee (IKDC) and Marx scores electronically and respond to questions regarding return to sports and subsequent surgeries. Nonresponders who completed the questionnaires after reminders were considered late responders. The remaining nonresponders were considered never-responders. The late responders (n = 367) completed the questionnaires after a mean follow-up of 7.8 years (range, 6.7-9.6 years), while follow-up for the responders was 6.8 years (range, 5.0-9.7 years). Responders and late responders were then compared in terms of differences in IKDC and Marx scores from baseline to final follow-up.
RESULTS
Nonresponders were younger (28.5 vs 31.5 years;
CONCLUSION
There was no difference in clinical outcome as evaluated using IKDC and Marx scores between responders and late responders.

Identifiants

pubmed: 34723674
doi: 10.1177/03635465211047858
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3809-3815

Auteurs

Per-Henrik Randsborg (PH)

Sports Medicine Institute, Hospital for Special Surgery, New York, New York, 10021 USA.

Dakota Adamec (D)

Sports Medicine Institute, Hospital for Special Surgery, New York, New York, 10021 USA.

Nicholas A Cepeda (NA)

Sports Medicine Institute, Hospital for Special Surgery, New York, New York, 10021 USA.

Andrew Pearle (A)

Sports Medicine Institute, Hospital for Special Surgery, New York, New York, 10021 USA.

Anil Ranawat (A)

Sports Medicine Institute, Hospital for Special Surgery, New York, New York, 10021 USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH